Navigation Links
Cardium Reports on First Quarter 2008 Highlights and Financial Results
Date:5/9/2008

SAN DIEGO, May 9 /PRNewswire-FirstCall/ -- Cardium Therapeutics (Amex: CXM) today reported recent highlights and developments, as well as financial results for its first quarter ended March 31, 2008.
(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

Highlights and Recent Developments

-- European commercialization agreement with Euromed Medizinisch GmbH

(Euromed) for InnerCool's CoolBlue(TM) surface temperature modulation

system and RapidBlue endovascular system. Euromed, a leading

distributor of cardiology medical products will have exclusive

marketing, sales and distribution rights in Austria, Germany and

Switzerland for InnerCool's portfolio of temperature modulation

systems.

-- Australian distribution agreement with Lifehealthcare Pty Ltd., one of

Australia's leading medical device distributors and health service

providers. Under the agreement, Lifehealthcare has the exclusive

rights to market, sell and distribute InnerCool's CoolBlue and

RapidBlue temperature modulation systems in Australia and New Zealand.

-- Publication by BioMed Central (BMC) Cardiovascular Disorders

(2008, 8:7, April 10, 2008) of positive findings from a preclinical

study conducted by researchers at Lund University Hospital in Sweden

demonstrating a new and expanded benefit of early rapid cooling for the

potential treatment of acute myocardial infarction (heart attack). The

same researchers are currently recruiting patients for the RAPID-MI-ICE

(Rapid Intravascular Cooling in Myocardial Infarction as Adjunctive to

Percutaneous Coronary Intervention) clinical study, which is expected

to enroll approximately 20 patients who present within six hours of

their hea
'/>"/>

SOURCE Cardium Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
2. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
3. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
4. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
5. Cardium Completes $5.3 Million Registered Direct Offering
6. Cardium Announces $5.3 Million Registered Direct Offering
7. Novavax Reports First Quarter 2008 Financial Results
8. Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
9. Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results
10. Pharmos Corporation Reports 2008 First Quarter Results
11. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...  Rahal Letterman Lanigan Racing (RLL) and StemCyte, Inc., ... banking and therapeutics, announced today that StemCyte has become ... Indy car driven by James Jakes ... IndyCar 2013 season.   StemCyte, Inc. and Rahal ... of umbilical cord blood banking and its educational initiative ...
(Date:5/23/2013)... PI’s new LPS-24 positioners are ... mm travel range with closed-loop sensor resolution up ... these new positioners the ideal choice for high ... version is also available. , More Information: ... be found at: , http://www.physikinstrumente.com/en/products/prdetail.php?sortnr=1000745&prw-lps24 , ...
(Date:5/23/2013)... May 23, 2013  Saddleback Memorial Medical Center in ... the first hospital on the West Coast to perform ... surgical option provides women with a state-of-the-art, minimally invasive ... Marc Winter , M.D., a highly regarded ... medical director of minimally invasive surgery at Saddleback Memorial, ...
(Date:5/23/2013)... 23, 2013 BioTrends Research Group, one ... for specialized biopharmaceutical issues, finds that, unaided, one ... specialists reported that in the past six months, ... treatment) in anticipation of the next generation of ... when only 6 percent reported that they had ...
Breaking Biology Technology:StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3
... International, LLC,(BioEnergy), a privately-held, biotech-based developer and ... the,acquisition of certain assets of OmniGene Bioproducts, ... employees. OBI, currently based in Cambridge,MA, possesses ... metabolic pathway engineering expertise to develop efficient ...
... to Provide an Attractive Domestic Alternative to ... 18 Fulcrum BioEnergy, Inc.,today announced that ... plans to build one of the first ... to ethanol. The plant will,process municipal solid ...
... China, July 18 /Xinhua-PRNewswire-FirstCall/ --,China-Biotics, Inc. (OTC ... Chinese firm specializing in the manufacture,research, development, ... it has applied for listing approval on ... an important milestone for China-Biotics, and we ...
Cached Biology Technology:BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc. 2BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc. 3Fulcrum BioEnergy Announces Plans to Build One of the First Commercial-Scale Ethanol Plants Using Municipal Solid Waste as Feedstock 2Fulcrum BioEnergy Announces Plans to Build One of the First Commercial-Scale Ethanol Plants Using Municipal Solid Waste as Feedstock 3China-Biotics, Inc. Files Application for Nasdaq Listing 2
(Date:5/23/2013)... Plant Science , Automated conserved ... and promoter evolution among grasses , Within the ... of DNA that undergo little change in position and ... for any proteins. Some of these evolutionarily stable sequences, ... the expression of other genes or the condensation of ...
(Date:5/23/2013)... RICHLAND, Wash. Pacific Northwest National Laboratory honored ... and commercialization of intellectual property at PNNL,s annual ... , The Department of Energy national laboratory ... Year for his work developing battery materials that ... to the electrical grid, and reduce the time ...
(Date:5/23/2013)... of Public Health at Emory University, along with ... received a $4 million grant over four years ... (Health and Exposome Research Center: Understanding Lifetime Exposures). ... awarded in the United States. , The ... of Environmental Health Sciences (NIEHS) of the National ...
Breaking Biology News(10 mins):Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3
... of the department of genetics, development and cell biology at ... work will be published in the Oct. 12 issue of ... of the green algae chlamydomonas, a single-celled alga that has ... of uses that come out of this, including basic bio-medical ...
... for researching and developing new biopharmaceuticals would be ... of dollars annually, according to a new economic ... and Technology (NIST). , Prepared by RTI ... over the last two decades emphasis in new ...
... project, 115 scientists from around the world report in the ... of data on a tiny green alga called Chlamydomonas, with ... organism that grows in soil and ponds, has approximately 15,000 ... of its genome. Several years ago, they knew less than ...
Cached Biology News:Biopharmaceutical infrastructure key to lower drug development costs 2Study involving more than 100 scientists provides new insights on green algae 2Study involving more than 100 scientists provides new insights on green algae 3Study involving more than 100 scientists provides new insights on green algae 4
... CRE-bla HEK 293T cell line contains the ... cAMP response element (CRE). To obtain the ... into HEK 293T cells by lentivirus. Subsequent ... responsive to forskolin stimulation (Figure 1). The ...
activating transcription factor 4 (tax-responsive enhancer element B67),...
Reactivity: Human...
... of BAC (100+kb), fosmid (40kb), and large ... than any othe BAC vector. On command ... and easy recombinant DNA purification. Available with ... VC) vectors for the highest insert stability. ...
Biology Products: